Dysembryoplastic Neuroepithelial Tumor (DNET) in Children

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Glioma Program

A dysembryoplastic neuroepithelial tumor (DNET or DNT) is a low-grade, slow-growing brain tumor. It is a glioneuronal tumor, which means it contains properties of both glial cells (responsible for providing the structural support of the central nervous system) and neuronal cells (the functioning component of the central nervous system).

  • DNET often causes seizures that don’t respond to medication.
  • DNET occurs in the tissues that cover the brain and spinal cord.
  • A DNET usually begins in children and teenagers who are 20 years old or younger.

How Dana-Farber/Boston Children's approaches DNET

Children with dysembryoplastic neuroepithelial tumors (DNETs) are treated through our Brain Tumor Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, a world-renowned destination for children with malignant and non-malignant brain and spinal cord tumors. Our brain tumor specialists have extensive expertise in treating all types of glial and neural tumors, including dysembryoplastic neuroepithelial tumor (DNET).

Learn more

Find in-depth information on dysembryoplastic neuroepithelial tumors (DNET) on the Dana-Farber/Boston Children's website, including details on dysembryoplastic neuroepithelial tumors (DNET) symptoms, diagnosis, treatment and more.

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close